 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/221581
Analgesics in France
|
Description: |
The Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.
Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics
Data coverage: market sizes (historic and forecasts), company shares, brand shares
Why buy this report? - Get a detailed picture of the analgesics industry - Pinpoint growth sectors and trends and identify factors driving change - Understand the competitive environment, the market’s major players and leading brands - Use five-year forecasts to assess how the market is predicted to develop |
|
Contents: |
Analgesics in France Euromonitor International April 2009 List of Contents and Tables Executive Summary OTC Healthcare Suffers From Consumers Obtaining More Prescription Products Increasing Presence of Self-service Areas in Chemists/pharmacies for OTC Products A Fragmented Market Led by OTC Manufacturers Chemists/pharmacies Remains the Leading Distribution Channel Positive Performance Through the Development of Self-medication Key Trends and Developments the Setting-up of Self-service: Its Impact on Self-medication Vitamins and Dietary Supplements for Everyone the Grey Market Is the New Key Target Consumer Group Decreasing Purchasing Power Favours Rx Products Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008 Table 2 Life Expectancy at Birth 2003-2008 Market Data Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 5 OTC Healthcare Company Shares by Value 2004-2008 Table 6 OTC Healthcare Brand Shares by Value 2005-2008 Table 7 Penetration of Private Label by Sector 2003-2008 Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008 Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008 Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013 Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013 Appendix OTC Registration and Classification Advertising Packaging and Labelling Distribution Vitamins & Dietary Supplements Registration and Classification EU Legislation Self-medication and Preventative Medicine Generics Switches Summary 1 Rx-to-OTC Healthcare Switches 2006-2008 Definitions Summary 2 Research Sources Arkopharma Sa, Laboratoires Pharmaceutiques Strategic Direction Key Facts Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators Company Background Competitive Positioning Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2008 Beaufour-ipsen SA Strategic Direction Key Facts Summary 6 Beaufour-Ipsen SA: Key Facts Summary 7 Beaufour-Ipsen SA: Operational Indicators Company Background Production Summary 8 Beaufour-Ipsen SA: Production Statistics 2007 Competitive Positioning Summary 9 Beaufour-Ipsen SA: Competitive Position 2008 Cooper SA Strategic Direction Key Facts Summary 10 Cooper SA: Key Facts Summary 11 Cooper SA: Operational Indicators Company Background Production Summary 12 Cooper SA: Production Statistics 2007 Competitive Positioning Summary 13 Cooper SA: Competitive Position 2008 GlaxoSmithKline Santé Grand Public Sas Strategic Direction Key Facts Summary 14 GlaxoSmithKline Santé Grand Public SAS: Key Facts Summary 15 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators Company Background Production Summary 16 GlaxoSmithKline France: Production Statistics 2007 Competitive Positioning Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2008 Juva Santé, Laboratoires Strategic Direction Key Facts Summary 18 Laboratoires Juva Santé: Key Facts Summary 19 Laboratoires Juva Santé: Operational Indicators Company Background Production Summary 20 Laboratoires Juva Santé: Production Statistics 2006 Competitive Positioning Summary 21 Laboratoires Juva Santé: Competitive Position 2008 Laboratoires Mcneil Strategic Direction Key Facts Summary 22 Laboratoires McNeil: Key Facts Summary 23 Laboratoires McNeil: Operational Indicators Company Background Competitive Positioning Summary 24 Laboratoires McNeil: Competitive Position 2008 Pierre Fabre Sa, Laboratoires Strategic Direction Key Facts Summary 25 Laboratoires Pierre Fabre SA: Key Facts Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators Company Background Production Summary 27 Laboratoires Pierre Fabre SA: Production Statistics 2007 Competitive Positioning Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2008 Théraplix SA Strategic Direction Key Facts Summary 29 Théraplix SA: Key Facts Company Background Competitive Positioning Summary 30 Théraplix SA: Competitive Position 2008 Upsa, Laboratoires Strategic Direction Key Facts Summary 31 Laboratoires UPSA: Key Facts Summary 32 Laboratoires UPSA: Operational Indicators Company Background Production Summary 33 UPSA Conseil SAS: Production Statistics 2007 Competitive Positioning Summary 34 UPSA Conseil SAS: Competitive Position 2008 Urgo, Laboratoires Strategic Direction Key Facts Summary 35 Laboratoires Urgo: Key Facts Summary 36 Laboratoires Urgo: Operational Indicators Company Background Production Competitive Positioning Summary 37 Laboratoires Urgo: Competitive Position 2008 Headlines Trends Competitive Landscape Prospects Sector Data Table 12 Sales of Analgesics by Subsector: Value 2003-2008 Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008 Table 14 Herbal vs Standard Topical Analgesics 2003-2008 Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008 Table 16 Analgesics Company Shares by Value 2004-2008 Table 17 Analgesics Brand Shares by Value 2005-2008 Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013 Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
|
|
Summary: |
Semi-ethical sales France is a market where the influence of semi ethical product sales on the market as a whole is significant. Although the French government has been involved in de-listing initiatives, the French national health service continues to offer a wide range of products which can be reimbursed by the state. At a time of relative economic hardship, this represents a very attractive option for a considerable number of consumers. |
|
Companies Mentioned |
Companies Mentioned Include:
- UCB-Pharma
- Laboratoires Bouchara-Recordati
- Laboratoires Schering-Plough
- UPSA, Laboratoires
- Théraplix SA
- Laboratoires Roche Nicholas SAS
- Pierre Fabre SA, Laboratoires
- Urgo, Laboratoires
- Sanofi-Synthélabo France SA
- GlaxoSmithKline Santé Grand Public SAS
- Laboratoires Martin-Johnson & Johnson-MSD SAS
- Beaufour-Ipsen SA
- Pfizer Santé Grand Public
- Arkopharma SA
- Ricola AG
- Juva Santé, Laboratoires
- Boots Healthcare International Ltd
- Whitehall Laboratories Ltd
- Pharmacia SNC
- Laboratoires du Docteur E Bouchara
- Janssen Cilag
- Lachartre, Laboratoire
- Novartis Group France SA
- Beiersdorf SA
- Boehringer Ingelheim France SAS
- Laboratoires Mercurochrome
- Solvay Pharma
- Viatris GmbH
- Gifrer Barbezat SA
- Laboratoire Oenobiol
- Orgamol SA
- Cadbury France SA
- Bayer Pharma SA
- Monot, Laboratoires
- Biogalénique RPG
- Cooper SA
- Menarini France SA
- Laboratoires Physcience
- Reckitt Benckiser France SA
- Johnson & Johnson Consumer France SAS
- Therval Médical
- Lofthouse of Fleetwood Ltd
- Jolly-Jattel SARL
- Biocodex SA, Laboratoires
- Vitarmonyl, Laboratoires
- Mayoly Spindler, Laboratoires
- Pharmygiène, Laboratoires
- Chauvin SA, Laboratoires
- Plantes et Médecines, Laboratoires
- Ferring Legemidler AS
- Merck Médication Familiale SAS
- Medix, Laboratoires
- Asta Médica SA
- Laboratoires HRA Pharma SA
- Alcon France SA, Laboratoires
- CIBA Vision SAS
- Laboratoires UPSA
- Etris SA, Laboratoires
- LEA Institut Vital, Groupe Naturland
- Ardeval-Chefaro
- CS Laboratoires SA
- Laboratoires Juva Santé
- Roche-Posay SA, Laboratoire
- Altana Pharma SA
- Stiefel SARL, Laboratoires
- Jouveinal, Groupe
- Sarget, Laboratoire
- Vichy SA, Laboratoire Industriel de (LIDV) EG Labo
- Médipha Santé SAS
- Brothier, Laboratoires
- Norgine Pharma
- LaboratoireThéramex SAM
- Santé Beauté SA, Laboratoires
- Clément, Laboratoires
- Biapharm SAS
- Byk France SA |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/221581
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 27/11/2009 04:01:19 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Analgesics in France
|
|
Web Address: |
http://www.researchandmarkets.com/reports/221581
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€675.00
|
|
Electronic (PDF)
- Site License
|
|
€1,350.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€2,025.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 27/11/2009 04:01:19
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|